Your session is about to expire
← Back to Search
Cardiac Rehabilitation for Stroke Survivors (SRP-CROSS Trial)
N/A
Recruiting
Led By Sara J Cuccurullo, MD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year post stroke
Awards & highlights
SRP-CROSS Trial Summary
This trial will study if cardiac rehab can help stroke patients recover better and reduce their risk of hospital readmission, recurrent stroke, and death.
Who is the study for?
This trial is for stroke survivors who are 18 or older, can follow commands and communicate discomfort, have been admitted to a rehab facility post-stroke, and cleared by a cardiologist. They must be able to stand and walk at least 10 feet with assistance if needed. Those with certain other brain conditions or medical issues that prevent participation in the study, unable to meet study requirements, non-English speakers, or diagnosed beyond 45 days post-stroke are excluded.Check my eligibility
What is being tested?
The SRP-CROSS trial is testing whether adding cardiac rehabilitation to standard care helps improve recovery after a stroke. It looks at whether this approach reduces hospital readmissions, recurrent strokes, and death rates among these patients.See study design
What are the potential side effects?
While specific side effects aren't listed for cardiac rehabilitation programs in this summary, such interventions may include general risks like muscle soreness or fatigue from exercise. The program should be tailored to each patient's abilities following their stroke.
SRP-CROSS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-year post stroke
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year post stroke
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
6-Minute Walk Test (6MWT)
Secondary outcome measures
AM-PAC - (Activity Measure for Post Acute Care)
All-cause hospital readmission
All-cause mortality rate
+7 moreSRP-CROSS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac rehabilitation groupExperimental Treatment1 Intervention
Traditional medically supervised center-based cardiac rehabilitation program; including 36 sessions (30-50 minutes) of a progressive exercise program and educational sessions for cardiovascular disease (CVD) risk factors.
Group II: Standard of careActive Control1 Intervention
Depending on functional deficits, conventional rehabilitation therapies can include physical therapy, occupational therapy, and/or speech therapy sessions with 2-3 visits per week. Participants will receive their standard of care therapies as prescribed by their treating physicians.
Find a Location
Who is running the clinical trial?
Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
28,132 Total Patients Enrolled
1 Trials studying Stroke
12 Patients Enrolled for Stroke
The Cardiovascular Institute of New Jersey at Rutgers Robert Wood Johnson Medical SchoolUNKNOWN
Sara J Cuccurullo, MDPrincipal InvestigatorHackensack Meridian Health - JFK Johnson Rehabilitation Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a brain bleed or abnormal blood vessels in my brain.I can understand simple instructions and express when I'm in pain or uncomfortable.My doctor expects I have less than 1 year to live due to my illness.I am 18 years old or older.I was unable to have an initial check-up within 60 days after my stroke diagnosis.My heart condition qualifies for rehab covered by insurance.I have been diagnosed with a stroke confirmed by imaging.I can get on and off a recumbent bike safely, with help if needed.A cardiologist has approved me for cardiac rehab without any restrictions.I was admitted to a rehab facility after having a stroke.
Research Study Groups:
This trial has the following groups:- Group 1: Cardiac rehabilitation group
- Group 2: Standard of care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining vacancies in this trial to which patients may apply?
"The clinical trial is no longer accepting patients as reported on clinicialtrials.gov; the initial posting was made on March 1st 2023 and the most recent update occurred December 7th 2022. Despite this, there are numerous other medical studies that require participants at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger